NM_001191061.2:c.464G>C

Variant summary

Our verdict is Likely benign. The variant received -5 ACMG points: 0P and 5B. BP4_StrongBS1_Supporting

The NM_001191061.2(SLC25A22):​c.464G>C​(p.Gly155Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000308 in 1,559,116 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G155C) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.00018 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000014 ( 0 hom. )

Consequence

SLC25A22
NM_001191061.2 missense

Scores

1
17

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:4

Conservation

PhyloP100: 0.768

Publications

1 publications found
Variant links:
Genes affected
SLC25A22 (HGNC:19954): (solute carrier family 25 member 22) This gene encodes a mitochondrial glutamate carrier. Mutations in this gene are associated with early infantile epileptic encephalopathy. Multiple alternatively spliced variants, encoding the same protein, have been identified.[provided by RefSeq, Jul 2010]
SLC25A22 Gene-Disease associations (from GenCC):
  • genetic developmental and epileptic encephalopathy
    Inheritance: AR, AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
  • developmental and epileptic encephalopathy, 3
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), PanelApp Australia, G2P
  • early myoclonic encephalopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • malignant migrating partial seizures of infancy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -5 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.023228854).
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.000184 (28/152298) while in subpopulation AFR AF = 0.000602 (25/41558). AF 95% confidence interval is 0.000418. There are 0 homozygotes in GnomAd4. There are 13 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001191061.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SLC25A22
NM_001191061.2
MANE Select
c.464G>Cp.Gly155Ala
missense
Exon 7 of 10NP_001177990.1Q9H936
SLC25A22
NM_001425334.1
c.539G>Cp.Gly180Ala
missense
Exon 7 of 10NP_001412263.1
SLC25A22
NM_001425335.1
c.503G>Cp.Gly168Ala
missense
Exon 7 of 10NP_001412264.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SLC25A22
ENST00000628067.3
TSL:1 MANE Select
c.464G>Cp.Gly155Ala
missense
Exon 7 of 10ENSP00000486058.1Q9H936
SLC25A22
ENST00000320230.9
TSL:1
c.464G>Cp.Gly155Ala
missense
Exon 7 of 10ENSP00000322020.5Q9H936
SLC25A22
ENST00000860087.1
c.539G>Cp.Gly180Ala
missense
Exon 7 of 10ENSP00000530146.1

Frequencies

GnomAD3 genomes
AF:
0.000184
AC:
28
AN:
152180
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000603
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000131
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.000478
GnomAD2 exomes
AF:
0.0000429
AC:
7
AN:
163258
AF XY:
0.0000225
show subpopulations
Gnomad AFR exome
AF:
0.000661
Gnomad AMR exome
AF:
0.0000384
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000142
AC:
20
AN:
1406818
Hom.:
0
Cov.:
32
AF XY:
0.0000115
AC XY:
8
AN XY:
696294
show subpopulations
African (AFR)
AF:
0.000339
AC:
11
AN:
32412
American (AMR)
AF:
0.0000536
AC:
2
AN:
37336
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25352
East Asian (EAS)
AF:
0.00
AC:
0
AN:
37142
South Asian (SAS)
AF:
0.00
AC:
0
AN:
81710
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
41318
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5708
European-Non Finnish (NFE)
AF:
0.00000368
AC:
4
AN:
1087346
Other (OTH)
AF:
0.0000513
AC:
3
AN:
58494
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.470
Heterozygous variant carriers
0
1
3
4
6
7
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000184
AC:
28
AN:
152298
Hom.:
0
Cov.:
33
AF XY:
0.000175
AC XY:
13
AN XY:
74464
show subpopulations
African (AFR)
AF:
0.000602
AC:
25
AN:
41558
American (AMR)
AF:
0.000131
AC:
2
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5192
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4830
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10626
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
68000
Other (OTH)
AF:
0.000473
AC:
1
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.509
Heterozygous variant carriers
0
2
4
7
9
11
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000310
Hom.:
0
Bravo
AF:
0.000200
ESP6500AA
AF:
0.000463
AC:
2
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.0000344
AC:
4

ClinVar

ClinVar submissions
Significance:Uncertain significance
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
2
-
not provided (2)
-
1
-
Developmental and epileptic encephalopathy (1)
-
1
-
Inborn genetic diseases (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.070
BayesDel_addAF
Benign
-0.30
T
BayesDel_noAF
Benign
-0.30
CADD
Benign
2.0
DANN
Benign
0.55
DEOGEN2
Benign
0.032
T
Eigen
Benign
-1.0
Eigen_PC
Benign
-1.1
FATHMM_MKL
Benign
0.18
N
LIST_S2
Benign
0.65
T
M_CAP
Uncertain
0.18
D
MetaRNN
Benign
0.023
T
MetaSVM
Benign
-0.90
T
MutationAssessor
Benign
-0.64
N
PhyloP100
0.77
PrimateAI
Benign
0.44
T
PROVEAN
Benign
0.24
N
REVEL
Benign
0.17
Sift
Benign
0.32
T
Sift4G
Benign
0.40
T
Polyphen
0.0010
B
Vest4
0.15
MVP
0.53
MPC
0.42
ClinPred
0.018
T
GERP RS
2.5
Varity_R
0.048
gMVP
0.60
Mutation Taster
=82/18
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs200992080; hg19: chr11-792676; COSMIC: COSV100204221; COSMIC: COSV100204221; API